BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition-Reference-Cited by-同舟云学术

BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition

Published:2005-12-07 Issue:2 Volume:14 Page:167-172
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Vahteristo Pia,Syrjäkoski Kirsi,Heikkinen Tuomas,Eerola Hannaleena,Aittomäki Kristiina,von Smitten Karl,Holli Kaija,Blomqvist Carl,Kallioniemi Olli-Pekka,Nevanlinna Heli

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics

Link

http://www.nature.com/articles/5201542.pdf

Reference23 articles.

1. Ford D, Easton DF, Stratton M et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 676–689.

2. Vahteristo P, Eerola H, Tamminen A, Blomqvist C, Nevanlinna H : A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast–ovarian cancer families. Br J Cancer 2001; 84: 704–708.

3. Meijers-Heijboer H, van den Ouweland A, Klijn J et al: Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002; 31: 55–59.

4. Vahteristo P, Bartkova J, Eerola H et al: A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 2002; 71: 432–438.

5. Kilpivaara O, Vahteristo P, Falck J et al: CHEK2 variant I157T may be associated with increased breast cancer risk. Int J Cancer 2004; 111: 543–547.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Fundamental Role of BARD1 Mutations and Their Applications as a Prognostic Biomarker for Cancer Treatment;BRCA1 and BRCA2 Mutations - Diagnostic and Therapeutic Implications;2023-01-18

2. Germline variants associated with breast cancer in Khakass women of North Asia;Molecular Biology Reports;2022-12-28

3. BARD1 mystery: tumor suppressors are cancer susceptibility genes;BMC Cancer;2022-06-01

4. The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer;Pharmacology & Therapeutics;2021-10

5. Gene Expression and Resistance to Glucocorticoid-Induced Apoptosis in Acute Lymphoblastic Leukemia: A Brief Review and Update;Current Drug Research Reviews;2021-01-11